Skip to main content
Addgene

pCDH-EF1a-hDNAJC6-T2A-copGFP
(Plasmid #170443)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 170443 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pCDH-EF1a-T2A-copGFP
  • Backbone manufacturer
    System Biosciences
  • Backbone size w/o insert (bp) 7430
  • Total vector size (bp) 10340
  • Vector type
    Lentiviral

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    human DNAJC6
  • Alt name
    Auxilin
  • Alt name
    DnaJ Heat Shock Protein Family (Hsp40) Member C6
  • Alt name
    PARK19
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    2910
  • GenBank ID
    BC109279.2
  • Entrez Gene
    DNAJC6 (a.k.a. DJC6, PARK19)
  • Promoter EF1a

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site EcoRI (not destroyed)
  • 3′ cloning site NotI (not destroyed)
  • 5′ sequencing primer GGATCTCGACGGTATCGG
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCDH-EF1a-hDNAJC6-T2A-copGFP was a gift from Sang-Hun Lee (Addgene plasmid # 170443 ; http://n2t.net/addgene:170443 ; RRID:Addgene_170443)
  • For your References section:

    Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked DNAJC6 mutations. Wulansari N, Darsono WHW, Woo HJ, Chang MY, Kim J, Bae EJ, Sun W, Lee JH, Cho IJ, Shin H, Lee SJ, Lee SH. Sci Adv. 2021 Feb 17;7(8). pii: 7/8/eabb1540. doi: 10.1126/sciadv.abb1540. Print 2021 Feb. 10.1126/sciadv.abb1540 PubMed 33597231